companydata.dkcompanydata.dk

LICA PHARMACEUTICALS ApS: Financial statements 2018

CVR: 25332520

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 973,018 and a net result of DKK 5,572,310 compared with DKK 812,469 the year before. That is an increase of 138.1% compared with the year before. Equity in the 2018 report amounted to DKK 18,367,765. The solvency ratio was 99.5%.

Gross Profit
DKK 973,018
Profit/Loss
DKK 5,572,310
Equity
DKK 18,367,765
Total Assets
DKK 18,457,147

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-973 t.5.6 mio.18.4 mio.-
2017-409 t.812 t.12.8 mio.-
2016-738 t.328 t.12 mio.-
2015-312 t.-2.3 mio.11.7 mio.-
2014-269 t.3.9 mio.13.9 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

LICA PHARMACEUTICALS ApS: The 2017 annual report is outApr 16, 2018

LICA PHARMACEUTICALS ApS has published its annual report for 2017. Gross profit came to DKK 408,690, and the net result was DKK 812,469.

About LICA PHARMACEUTICALS ApS

LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The company has 1 employee (2013). In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity in the 2025 report amounted to DKK 24,221,286.

Source: annual report 2025, Danish Business Authority